Well...I would say it at least wouldn't be a 'crowded' trade -)...endpts.com/why-scott-gottlie… @ScottGottliebMD
AMR and surprise billing! month in hospital from a HOSPITAL infection...and then got the bill. khn.org/news/even-with-insur…
You can run but cant hide! wsj.com/articles/superbug-fr…
Indeed, "Finding new medicines to kill pathogenic bacteria is getting harder and harder,"--AND finding a commercialization path is nigh impossible. cen.acs.org/pharmaceuticals/…
2
If this was in the US...maybe we'd be having different conversations? aricjournal.biomedcentral.co…
more concerned they have a "curator" position at all.
After outcry, NIH apologizes for turning away portrait of person with rare disease statnews.com/2018/12/09/rare… via @statnews
$AKAO diagnostic stewardship. finance.yahoo.com/news/achao…
two important related studies: 1) the-scientist.com/news-opini… 2) healio.com/infectious-diseas…
Vaccines are part of the solution to the emerging crisis of antibiotic resistance statnews.com/2017/08/01/anti… via @statnews
Risk of drug resistance in repeat gram-negative infections among patients with multiple hospitalizations. - PubMed ncbi.nlm.nih.gov/pubmed/2894…
Novel antimcrobial products--highly cost effect. @LEK Consulting Report. lek.com/our-publications/lek…
Antimicrobial Innovation Alliance retweeted
The Puzzle of Antibiotic #Innovation - @koutterson on Health Affairs Blog: http://t.co/YGCJwMqe8j #antibioticresistance @PetrieFlom
Antimicrobial Innovation Alliance retweeted
Astellas' new antibiotic marches toward FDA approval with panel nod. fiercebiotech.com/story/aste… by @DamianFierce



